Does CBD Hold Key to Antibiotic Resistance?

Researchers have reported that CBD, one of the compounds found in hemp, has shown promise against antibiotic resistant infections such as methicillin-resistant S. aureus (MRSA). This is in addition to the other benefits of CBD for pain, anxiety, and a number of other conditions. We must ensure that the FDA does not make CBD a monopoly drug and allows CBD to be sold in supplements at therapeutic levels. The researchers found that CBD was “remarkably effective” at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment. Gram-positive bacteria, as opposed to Gram-negative bacteria, refers to bacteria that give a positive result in the Gram strain test, which is used to classify bacteria into two categories according to their cell wall. Additionally, CBD was effective at disrupting biofilms, a form of bacteria growth that leads to difficult-to-treat infections.

Will the FDA Ban Hemp Oil?

ANH-USA has been keeping a close watch as the FDA determines how it will treat hemp products. We’ve noted that the FDA has targeted CBD oil, a natural compound found in hemp that is now approved as a drug. But many other products could fall in the FDA’s net, including full-spectrum hemp oil, depending on how the agency decides to move forward. Luckily there is now a bill that would protect hemp-derived CBD from the FDA. Natural health advocates must come out in support of this important measure. The bill is simple. It amends the law to provide an exemption for hemp-derived CBD and any “hemp-derived CBD-containing substance” from rules that apply to dietary supplements when there is an approved drug with that ingredient or if that ingredient is being investigated as a new drug. If approved as is, this bill would allow hemp-derived CBD supplements and hemp oils containing CBD to be sold.

The CBD Health Revolution is Online and FREE

Is CBD really the wonder medicine it’s purported to be? Join us to learn about the revolutionary healing properties of CBD (legal in all 50 US states) for chronic pain, insomnia, addiction, cancer, epilepsy, anxiety, PTSD, diabetes, skin issues, MS, Alzheimer's and other conditions! The CBD Health Revolution is online and FREE from January 13-19, 2020. You’ve probably heard of “CBD” by now, since it became legal in the US it has been added to many coffee shops, gas stations and retail stores. However, not all CBD products are the same! It’s vital for you to learn why and when to use it, where to find it and how to use it properly. We’re collectively re-learning the many ways CBD can be applied to enhance health — even though the plant has been around for thousands of years — both as a preventative and a restorative solution, as well as how to apply it to cooking, feeling more energetic and enhancing your love life.

FDA Cracks Down on CBD Oil – Not Approved as a Supplement

Unless the FDA makes an exception, consumers will lose access to affordable CBD oil. Over the last couple of years, ANH has been reporting on the many benefits of CBD oil, a non-psychoactive compound found in the hemp plant. Among other things, CBD oil is extremely helpful in managing pain. You might think that, in the midst of a crippling epidemic of opioid addiction, a public health agency would be interested in preserving access to affordable, non-addictive pain remedies. But the FDA could shut the door permanently on consumer access to affordable CBD oil, unless concerned citizens make their voices heard. The agency has sent warning letters to several CBD companies for making illegal disease claims. It is shocking that this issue has come to this. Deaths from fentanyl, an FDA-approved drug, and other synthetic opioids reached an appalling 30,000 in 2018. When a safe, non-addictive, and effective alternative to deadly opioids is found, it is snatched away by Big Pharma with the help of the FDA, whose mission it is to protect public health. It is one of the most shameful examples of crony capitalism in recent memory.

$32,500 a Year for CBD Oil? FDA’s Absurd Logic On CBD

We’ve been monitoring the FDA’s treatment of CBD oil, a cheap, safe, and effective natural medicine for pain and other ailments. The agency has stated that CBD is not a supplement, and part of their justification is that it wasn’t marketed as a dietary ingredient before 1994. Recent evidence has surfaced, however, that clearly shows cannabis was consumed as food for centuries in many different countries. But because of a technicality, it is unlikely that the FDA will consider this evidence that would allow CBD to remain on the market as a supplement—meaning that consumers will have to shell out $32,500 a year for CBD oil.

Greater Access to Full Spectrum Hemp Oil can Supply CBD Benefits

Full plant hemp sources of CBD (cannabidiol) are about to become more accessible to everyone in the USA. Growing hemp as a cash crop was reinstated legally December 20, 2018, when President Trump signed the 2019 Farm Bill Congress had approved. Reinstating hemp agriculture has ramifications that go beyond the material wonders hemp can create. There are health and medical ramifications that we can all use without legal concerns as well with full spectrum hemp CBD oil that will be more available now.

Study: Non-psychoactive CBD Oil Effective in Reducing Anxiety

The legality of CBD (cannabidiol) oil has been a subject of confusion and misinformation. Simply put, CBD oil from industrial hemp is perfectly legal in all 50 states as long as it is sold as a supplement. In other words, it cannot claim to cure or remedy any ailment. The information on what CBD oil can do is spreading through many internet articles and sites that are easily accessible to the public. This can be a boon for many who suffer from various forms of anxiety but reside in states that do not permit medical marijuana use. A 2011 Brazilian human study demonstrated efficacy without side effects for anxiety using CBD only. Prior to the human study, an animal (mouse) study demonstrate the same results. Anxiety is an umbrella term that covers several variations of nervous system disorders involving situations that trigger often overwhelming fear, panic attacks, dread, depression. PTSD (post traumatic stress disorder) that many military veterans suffer from. A large segment of our society, over 25 percent, suffers from mild to debilitating aspects of anxiety. CBD’s legality and access would be of great value to them as well as the almost 8 million PTSD sufferers.

World Health Organization Moving Towards Recommending Cannabis for Medical Purposes

In late December 2017, the WHO (World Health Organization) issued a statement from its Expert Committee on Drug Dependence (ECDD): "Recent evidence from animal and human studies shows that its use could have some therapeutic benefit for seizures due to epilepsy and related conditions. Current evidence also shows that cannabidiol is not likely to be abused or create dependence, such as for other cannabinoids (such as Tetra Hydro Cannabinol (THC), for instance)." Now that the WHO's own Expert Committee on Drug Dependence is heading for a final meeting in June to finalize its decision on CBD and review other whole-plant cannabis products for medical purposes, the FDA has been put into a position where it's forced to conduct a public survey for input on marijuana's medical efficacy and safety.

CBD from Medical Marijuana Offers Safe and Effective Recovery from Strokes

People who survive strokes are often encumbered with neurological issues that can be very debilitating and without quality of life. The rehabilitation methods for stroke victims under mainstream medical care are long and arduous, often with very little improvement. Now a potential cannabis solution has been discovered with a study published in April of 2017. The cannabis solution does not involve THC (tetrahydrocannabinol) the psychoactive compound. Instead, the chemical solution for neurological damage in the aftermath of cerebral ischemia is CBD or cannabidiol, which is a major cannabinoid among at least 85 cannabinoids found in cannabis.

New Bills Proposed to Protect Consumer Access to Medical Marijuana Extract

Two bills have been introduced to protect consumer access to cannabidiol (CBD). We have a growing opioid painkiller epidemic in this country—one that has followed the scandal of so many heart-health-destroying or cancer-causing pain relievers being approved by the FDA. There is a natural alternative, and of course the government is intent on banning it for no reason at all—other than to clear the way for a blockbuster new drug. Rep. Morgan Griffith (R-VA) has introduced two bills, the Legitimate Use of Medical Marijuana Act (HR 714) and the Compassionate Access Act (HR 715), both aimed at removing federal obstacles that prevent patient access to CBD, a medicinal extract of the marijuana plant. These bills follow a recent move by the Drug Enforcement Agency (DEA) that classified marijuana and all its extracts as Schedule I controlled substances—a category that includes heroin, LSD, mescaline, and MDMA. Note that none of the CBD extracts contains significant amounts of the psychoactive chemical in marijuana—only the non-psychoactive painkilling chemicals. Although “CBD” or “cannibinoids” are not mentioned in the Controlled Substances Act (CSA)—the legislation that the DEA must follow in creating rules related to controlled substances—the agency nonetheless lumps CBD and all other constituents of the plant into the definition of “marijuana.”